The isoprostanes--25 years later.

Area of Science:

• Biochemistry
• Lipidomics
• Oxidative Stress Research

Background:

• Isoprostanes (IsoPs) are prostaglandin-like compounds generated via free radical-induced peroxidation of arachidonic acid, independent of cyclooxygenase (COX).
• Initial discoveries focused on F2-IsoPs, but diverse IsoP structures and origins from various polyunsaturated fatty acids (PUFAs) are now recognized.
• The in vivo identification of IsoPs in humans has significantly advanced lipid oxidation and free radical research over 25 years.

Purpose of the Study:

• To review recent developments in isoprostane research, emphasizing clinical applications.
• To highlight the role of IsoPs as biomarkers and mediators of oxidative stress in diverse disease settings.
• To examine the influence of diet and lifestyle factors on endogenous IsoP levels.

Main Methods:

• Literature review focusing on recent clinical research and advancements in isoprostane analysis.
• Synthesis of findings on IsoPs as biomarkers in specific conditions like obesity, ischemia-reperfusion injury, CNS disorders, cancer, and genetic disorders.
• Analysis of studies investigating the impact of dietary and lifestyle factors on isoprostane levels.

Main Results:

• Isoprostanes are established biomarkers and mediators of oxidative stress across numerous diseases.
• Clinical research increasingly utilizes IsoPs for monitoring disease progression and therapeutic responses.
• Dietary components and lifestyle choices demonstrably influence endogenous isoprostane concentrations.

Conclusions:

• Isoprostanes are critical indicators and active participants in oxidative stress-related pathologies.
• Further clinical research is warranted to fully leverage IsoPs in disease management and prevention.
• Understanding modifiable factors affecting IsoP levels offers therapeutic potential.